Identifying the Pathological Domain of Alpha- Synuclein as a Therapeutic for Parkinson’s Disease.

Identifying the Pathological Domain of Alpha- Synuclein as a Therapeutic for Parkinson’s Disease.
Related ArticlesIdentifying the Pathological Domain of Alpha- Synuclein as a Therapeutic for Parkinson's Disease. Int J Mol Sci. 2019 May 11;20(9): Authors: Shen N, Song G, Yang H, Lin X, Brown B, Hong Y, Cai J, Cao C Abstract Alpha-synuclein is considered the major pathological protein associated with Parkinson's disease, but there is still no effective immunotherapy which targets alpha-synuclein. ... read more
Source: PubMedPublished on 2019-05-15